US Patent

US11975017 — Compositions comprising an RNA polymerase inhibitor and cyclodextrin for treating viral infections

Formulation · Assigned to Gilead Sciences Inc · Expires 2038-07-10 · 12y remaining

Vulnerability score 38/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a composition containing Compound 1, cyclodextrin, and optional pH adjusting agents for treating viral infections.

USPTO Abstract

The present disclosure provides a composition comprising Compound 1, or a pharmaceutically acceptable salt thereof, cyclodextrin, and, optionally, pH adjusting agents.

Drugs covered by this patent

Patent Metadata

Patent number
US11975017
Jurisdiction
US
Classification
Formulation
Expires
2038-07-10
Drug substance claim
No
Drug product claim
Yes
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.